{
    "Trade/Device Name(s)": [
        "BioPlex\u00ae 2200 Antiphospholipid Syndrome (APLS) IgM Kit",
        "BioPlex\u00ae 2200 Antiphospholipid Syndrome (APLS) IgM Calibrator Set",
        "BioPlex\u00ae 2200 Antiphospholipid Syndrome (APLS) IgM Control Set"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K130528",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092181",
        "K091556"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MID",
        "MSV",
        "JIX",
        "JJX"
    ],
    "Summary Letter Date": "October 21, 2013",
    "Summary Letter Received Date": "October 10, 2013",
    "Submission Date": "October 1, 2013",
    "Regulation Number(s)": [
        "21CFR866.5660",
        "21CFR862.1150",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system",
        "Calibrator",
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgM antibodies to Cardiolipin",
        "IgM antibodies to Beta-2-Glycoprotein I"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (lithium heparin, sodium heparin, sodium citrate)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Bio-Rad BioPlex 2200 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay",
        "Bead-based immunoassay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Semi-quantitative multiplexed flow immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent Kit"
    ],
    "Document Summary": "FDA 510(k) summary for BioPlex\u00ae 2200 Antiphospholipid Syndrome (APLS) IgM multiplex flow immunoassay for the detection of IgM antibodies to Cardiolipin and Beta-2-Glycoprotein I.",
    "Indications for Use Summary": "Aids in the diagnosis of primary Antiphospholipid Syndrome (APS) and APS secondary to systemic lupus erythematosus or SLE-like disorders by detecting IgM antibodies to Cardiolipin and Beta-2-Glycoprotein I in human serum and plasma, used with the Bio-Rad BioPlex 2200 System.",
    "fda_folder": "Immunology"
}